Compound as mTOR inhibitor and use thereof
US11649231B2 · kind B2 · utility
0Cited by
5References
8Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Oct 26, 2020 |
| Grant date | May 16, 2023 |
| Priority date | — |
| Expiry date | Oct 26, 2040 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D417/06
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to a novel compound as an mTOR inhibitor and a use thereof and, more specifically, to a novel compound represented by formula 1 that exhibits mTOR inhibitory activity and a pharmaceutical composition comprising same as an active ingredient for preventing or treating brain diseases associated with an mTOR pathway.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.